Clinical Risk Prediction Scores in Coronavirus Disease 2019: Beware of Low Validity and Clinical Utility
Several risk stratification tools were developed to predict disease progression in coronavirus disease 2019, with no external validation to date. We attempted to validate three previously published risk-stratification tools in a multicenter study. Primary outcome was a composite outcome of developme...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a8aac6d750354c48bb0c861f989bca7e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a8aac6d750354c48bb0c861f989bca7e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a8aac6d750354c48bb0c861f989bca7e2021-11-25T07:52:32ZClinical Risk Prediction Scores in Coronavirus Disease 2019: Beware of Low Validity and Clinical Utility2639-802810.1097/CCE.0000000000000253https://doaj.org/article/a8aac6d750354c48bb0c861f989bca7e2020-10-01T00:00:00Zhttp://journals.lww.com/10.1097/CCE.0000000000000253https://doaj.org/toc/2639-8028Several risk stratification tools were developed to predict disease progression in coronavirus disease 2019, with no external validation to date. We attempted to validate three previously published risk-stratification tools in a multicenter study. Primary outcome was a composite outcome of development of severe coronavirus disease 2019 disease leading to ICU admission or death censored at hospital discharge or 30 days. We collected data from 169 patients. Patients were 73 years old (59–82 yr old), 66 of 169 (39.1%) were female, 57 (33.7%) had one comorbidity, and 80 (47.3%) had two or more comorbidities. Area under the receiver operating characteristic curve (95% CI) for the COVID-GRAM score was 0.636 (0.550–0.722), for the CALL score 0.500 (0.411–0.589), and for the nomogram 0.628 (0.543–0.714).Haamed Al Hassan, MB BChEve Cocks, DNLara Jesani, MB BChSally Lewis, MRCGPTamas Szakmany, MD, PhDon behalf of the Gwent COVID-19 GroupA. Allen-RidgeE. BakerC. BaileyT. BaumerS. BeckettS. ChampanerkarY. CheemaS. CherianE. CocksS. CutlerE. DaweA. DhaddaS. DumontN. DuricS. ElgarfT. EvansE. GodfreyL. HardingD. HepburnA. E. HeronL. JesaniP. JonesC. KillickC. KingA. KissJ. LaversJ. Lloyd-EvansN. MasonL. McClellandB. MuthuswamyJ. Parry-JonesE. PhillipsS. PooleyB. RadfordO. RichardsA. RimmerG. RobertsA. Roynon-ReedA. SieunarineK. SullivanT. SzakmanyC. ThomasE. ThomasJ. TozerT. WestM. WinstanleyWolters KluwerarticleMedical emergencies. Critical care. Intensive care. First aidRC86-88.9ENCritical Care Explorations, Vol 2, Iss 10, p e0253 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 |
spellingShingle |
Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 Haamed Al Hassan, MB BCh Eve Cocks, DN Lara Jesani, MB BCh Sally Lewis, MRCGP Tamas Szakmany, MD, PhD on behalf of the Gwent COVID-19 Group A. Allen-Ridge E. Baker C. Bailey T. Baumer S. Beckett S. Champanerkar Y. Cheema S. Cherian E. Cocks S. Cutler E. Dawe A. Dhadda S. Dumont N. Duric S. Elgarf T. Evans E. Godfrey L. Harding D. Hepburn A. E. Heron L. Jesani P. Jones C. Killick C. King A. Kiss J. Lavers J. Lloyd-Evans N. Mason L. McClelland B. Muthuswamy J. Parry-Jones E. Phillips S. Pooley B. Radford O. Richards A. Rimmer G. Roberts A. Roynon-Reed A. Sieunarine K. Sullivan T. Szakmany C. Thomas E. Thomas J. Tozer T. West M. Winstanley Clinical Risk Prediction Scores in Coronavirus Disease 2019: Beware of Low Validity and Clinical Utility |
description |
Several risk stratification tools were developed to predict disease progression in coronavirus disease 2019, with no external validation to date. We attempted to validate three previously published risk-stratification tools in a multicenter study. Primary outcome was a composite outcome of development of severe coronavirus disease 2019 disease leading to ICU admission or death censored at hospital discharge or 30 days. We collected data from 169 patients. Patients were 73 years old (59–82 yr old), 66 of 169 (39.1%) were female, 57 (33.7%) had one comorbidity, and 80 (47.3%) had two or more comorbidities. Area under the receiver operating characteristic curve (95% CI) for the COVID-GRAM score was 0.636 (0.550–0.722), for the CALL score 0.500 (0.411–0.589), and for the nomogram 0.628 (0.543–0.714). |
format |
article |
author |
Haamed Al Hassan, MB BCh Eve Cocks, DN Lara Jesani, MB BCh Sally Lewis, MRCGP Tamas Szakmany, MD, PhD on behalf of the Gwent COVID-19 Group A. Allen-Ridge E. Baker C. Bailey T. Baumer S. Beckett S. Champanerkar Y. Cheema S. Cherian E. Cocks S. Cutler E. Dawe A. Dhadda S. Dumont N. Duric S. Elgarf T. Evans E. Godfrey L. Harding D. Hepburn A. E. Heron L. Jesani P. Jones C. Killick C. King A. Kiss J. Lavers J. Lloyd-Evans N. Mason L. McClelland B. Muthuswamy J. Parry-Jones E. Phillips S. Pooley B. Radford O. Richards A. Rimmer G. Roberts A. Roynon-Reed A. Sieunarine K. Sullivan T. Szakmany C. Thomas E. Thomas J. Tozer T. West M. Winstanley |
author_facet |
Haamed Al Hassan, MB BCh Eve Cocks, DN Lara Jesani, MB BCh Sally Lewis, MRCGP Tamas Szakmany, MD, PhD on behalf of the Gwent COVID-19 Group A. Allen-Ridge E. Baker C. Bailey T. Baumer S. Beckett S. Champanerkar Y. Cheema S. Cherian E. Cocks S. Cutler E. Dawe A. Dhadda S. Dumont N. Duric S. Elgarf T. Evans E. Godfrey L. Harding D. Hepburn A. E. Heron L. Jesani P. Jones C. Killick C. King A. Kiss J. Lavers J. Lloyd-Evans N. Mason L. McClelland B. Muthuswamy J. Parry-Jones E. Phillips S. Pooley B. Radford O. Richards A. Rimmer G. Roberts A. Roynon-Reed A. Sieunarine K. Sullivan T. Szakmany C. Thomas E. Thomas J. Tozer T. West M. Winstanley |
author_sort |
Haamed Al Hassan, MB BCh |
title |
Clinical Risk Prediction Scores in Coronavirus Disease 2019: Beware of Low Validity and Clinical Utility |
title_short |
Clinical Risk Prediction Scores in Coronavirus Disease 2019: Beware of Low Validity and Clinical Utility |
title_full |
Clinical Risk Prediction Scores in Coronavirus Disease 2019: Beware of Low Validity and Clinical Utility |
title_fullStr |
Clinical Risk Prediction Scores in Coronavirus Disease 2019: Beware of Low Validity and Clinical Utility |
title_full_unstemmed |
Clinical Risk Prediction Scores in Coronavirus Disease 2019: Beware of Low Validity and Clinical Utility |
title_sort |
clinical risk prediction scores in coronavirus disease 2019: beware of low validity and clinical utility |
publisher |
Wolters Kluwer |
publishDate |
2020 |
url |
https://doaj.org/article/a8aac6d750354c48bb0c861f989bca7e |
work_keys_str_mv |
AT haamedalhassanmbbch clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT evecocksdn clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT larajesanimbbch clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT sallylewismrcgp clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT tamasszakmanymdphd clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT onbehalfofthegwentcovid19group clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT aallenridge clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT ebaker clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT cbailey clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT tbaumer clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT sbeckett clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT schampanerkar clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT ycheema clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT scherian clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT ecocks clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT scutler clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT edawe clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT adhadda clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT sdumont clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT nduric clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT selgarf clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT tevans clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT egodfrey clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT lharding clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT dhepburn clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT aeheron clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT ljesani clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT pjones clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT ckillick clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT cking clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT akiss clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT jlavers clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT jlloydevans clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT nmason clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT lmcclelland clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT bmuthuswamy clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT jparryjones clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT ephillips clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT spooley clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT bradford clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT orichards clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT arimmer clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT groberts clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT aroynonreed clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT asieunarine clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT ksullivan clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT tszakmany clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT cthomas clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT ethomas clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT jtozer clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT twest clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility AT mwinstanley clinicalriskpredictionscoresincoronavirusdisease2019bewareoflowvalidityandclinicalutility |
_version_ |
1718413639266861056 |